Published in Clinical Oncology Week, September 11th, 2006
"Indolent lymphoproliferative disorders are incurable with conventional chemotherapy. Exploring the potential of allogeneic transplantation to eradicate disease has therefore been of interest for some time.
"This review reports on recent developments in this field to evaluate the current status of stem cell transplantation in the management of these conditions," wrote investigators in England.
According to K.J. Thomson and colleagues at Royal Free & University College Medical School in London, "Most recent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.